Clincosm LogoSign in Get a demo

salivary gland cancer

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

Not yet recruiting
  • Salivary Gland Cancer
  • vedicitumomab (Edisil, RC48）
  • +3 more
  • (no location specified)
Jun 9, 2023

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,

Recruiting
  • Salivary Gland Cancer
  • HER2 Gene Mutation
  • Ado-trastuzumab (T) emtansine (T-DM1)
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 2, 2023

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

Recruiting
  • Adenoid Cystic Carcinoma
  • Salivary Gland Cancer
  • Miami, Florida
  • +7 more
Oct 26, 2022

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

Recruiting
  • Salivary Gland Cancer
  • Salivary Duct Carcinoma
  • 68Ga-PSMA-PET/CT
  • 18FDG-PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 15, 2022

Salivary Gland Cancer Trial in Cincinnati (Amivantamab)

Recruiting
  • Salivary Gland Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Aug 5, 2022

European Reference Network on Rare Adult Solid Cancers

Recruiting
  • Head and Neck Cancer
  • +4 more
  • observation
  • Brno, Czechia
  • +10 more
Aug 1, 2022

Salivary Gland Cancer, Salivary Gland Tumors Trial in Novi Sad (Surgical intervention with or without postoperative adjuvant

Completed
  • Salivary Gland Cancer
  • Salivary Gland Neoplasms
  • Surgical intervention with or without postoperative adjuvant therapy
  • Novi Sad, Serbia
    Clinic for maxillofacial surgery Clinical center of Vojvodina
May 22, 2022

Thyroid Cancer, Salivary Gland Cancer Trial in Chicago (Pembrolizumab, Docetaxel)

Recruiting
  • Thyroid Cancer
  • Salivary Gland Cancer
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 13, 2022

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

    Withdrawn
    • Salivary Gland Carcinoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Feb 5, 2022

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

    Recruiting
    • Malignant Salivary Gland Cancer
    • Salivary Gland Cancer
    • Tampa, Florida
    • +2 more
    Feb 10, 2022

    Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

    Recruiting
    • Metastatic Breast Carcinoma
    • +13 more
    • 68GaNOTA-Anti-HER2 VHH1
    • Brussels, Brussel, Belgium
      Uz Brussel
    Dec 17, 2021

    Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Oct 15, 2021

    Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)

    Recruiting
    • Head and Neck Cancer
    • +26 more
    • Liquid biopsy
    • Copenhagen, Region Hovedstaden, Denmark
      University Hospital of Copenhagen, Rigshospitalet
    Sep 14, 2021

    Salivary Gland Cancer Trial in Seoul (docetaxel plus Cisplatin)

    Active, not recruiting
    • Salivary Gland Cancer
    • docetaxel plus Cisplatin
    • Seoul, Gangnamgu, Korea, Republic of
      Samsung Medical Center
    Aug 16, 2021

    Salivary Gland Cancer Trial in Nijmegen (Cabozantinib)

    Terminated
    • Salivary Gland Cancer
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Mar 11, 2021

    Squamous Cell Carcinoma of the Head and Neck, Nasopharyngeal Carcinoma, Salivary Gland Cancer Trial in Saint Louis (stereotactic

    Completed
    Has Results
    • Squamous Cell Carcinoma of the Head and Neck
    • +7 more
    • stereotactic body radiotherapy
    • Stereotactic body radiotherapy
    • Saint Louis, Missouri
      St. John's Mercy Medical Center
    Mar 28, 2020

    Salivary Gland Cancer Trial in Milano (Sorafenib)

    Completed
    • Salivary Gland Cancer
    • Milano, Italy
      IRCCS Istituto Nazionale Tumori
    Aug 23, 2019